Raras
Buscar doenças, sintomas, genes...
Doença isolada do complexo da fosforilação oxidativa
ORPHA:254846DOENÇA RARA

É um problema na forma como as mitocôndrias produzem energia, onde os complexos respiratórios (de I a V) não funcionam corretamente. Isso geralmente acontece por causa de alterações (mutações) nos genes que dão as instruções para as proteínas desses complexos específicos ou para os componentes que ajudam na sua montagem.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É um problema na forma como as mitocôndrias produzem energia, onde os complexos respiratórios (de I a V) não funcionam corretamente. Isso geralmente acontece por causa de alterações (mutações) nos genes que dão as instruções para as proteínas desses complexos específicos ou para os componentes que ajudam na sua montagem.

🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
89 sintomas
💪
Músculos
31 sintomas
❤️
Coração
26 sintomas
👁️
Olhos
24 sintomas
🫃
Digestivo
24 sintomas
🫁
Pulmão
19 sintomas

+ 212 sintomas em outras categorias

Características mais comuns

Tetraparesia
Miopatia mitocondrial
Diabetes mellitus
Movimentos oculares involuntários paroxísticos
Tubulopatia proximal
Lesão focal hiperintensa em T2 no tronco cerebral
513sintomas
Sem dados (513)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 513 características clínicas mais associadas, ordenadas por frequência.

TetraparesiaTetraparesis
Miopatia mitocondrialMitochondrial myopathy
Diabetes mellitus
Movimentos oculares involuntários paroxísticosParoxysmal involuntary eye movements
Tubulopatia proximalProximal tubulopathy

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa12
Últimos 10 anos200publicações
Pico202125 papers
Linha do tempo
20202014Hoje · 2026📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

68 genes identificados com associação a esta condição.

NDUFAF6NADH dehydrogenase (ubiquinone) complex I, assembly factor 6Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I) at early stages. May play a role in the biogenesis of complex I subunit MT-ND1

LOCALIZAÇÃO

Mitochondrion inner membraneCytoplasmNucleus

VIAS BIOLÓGICAS (1)
Complex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 17

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN17 transmission pattern is consistent with autosomal recessive inheritance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
7.9 TPM
Tireoide
7.7 TPM
Testículo
7.2 TPM
Nervo tibial
7.0 TPM
Cerebelo
6.5 TPM
OUTRAS DOENÇAS (3)
mitochondrial complex I deficiency, nuclear type 17Fanconi renotubular syndrome 5primary Fanconi syndrome
HGNC:28625UniProt:Q330K2
COX4I2Cytochrome c oxidase subunit 4 isoform 2, mitochondrialCandidate gene tested inTolerante
FUNÇÃO

Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (4)
Cytoprotection by HMOX1Respiratory electron transportTP53 Regulates Metabolic GenesComplex IV assembly
MECANISMO DE DOENÇA

Exocrine pancreatic insufficiency dyserythropoietic anemia and calvarial hyperostosis

Patients present with pancreatic insufficiency, intestinal malabsorption, failure to thrive, and anemia soon after birth.

OUTRAS DOENÇAS (1)
pancreatic insufficiency-anemia-hyperostosis syndrome
HGNC:16232UniProt:Q96KJ9
NDUFB10NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10Candidate gene tested inTolerante
FUNÇÃO

Accessory subunit that is involved in the functional assembly of the mitochondrial respiratory chain complex I. Complex I has an NADH dehydrogenase activity with ubiquinone as an immediate electron acceptor and mediates the transfer of electrons from NADH to the respiratory chain

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 35

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN35 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
429.8 TPM
Coração - Ventrículo esquerdo
333.6 TPM
Coração - Átrio
274.1 TPM
Cólon sigmoide
250.9 TPM
Esôfago - Muscular
212.3 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex 1 deficiency, nuclear type 35mitochondrial complex I deficiency
HGNC:7696UniProt:O96000
NDUFB11NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrialCandidate gene tested inDesconhecido
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Linear skin defects with multiple congenital anomalies 3

A disorder characterized by dermal, ocular, neurological and cardiac abnormalities. LSDMCA3 clinical features include linear skin defects on face and neck at birth, lacrimal duct atresia, myopia, nystagmus, strabismus, cardiomyopathy, axial hypotonia, seizures, corpus callosum agenesis, and dilation of lateral ventricles.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
325.4 TPM
Tireoide
275.3 TPM
Pituitária
235.7 TPM
Glândula adrenal
230.6 TPM
Linfócitos
219.9 TPM
OUTRAS DOENÇAS (4)
mitochondrial complex I deficiency, nuclear type 30linear skin defects with multiple congenital anomalies 3linear skin defects with multiple congenital anomaliesmitochondrial complex I deficiency
HGNC:20372UniProt:Q9NX14
COX6A2Cytochrome c oxidase subunit 6A2, mitochondrialCandidate gene tested inTolerante
FUNÇÃO

Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (4)
Cytoprotection by HMOX1Respiratory electron transportTP53 Regulates Metabolic GenesComplex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 18

An autosomal recessive, muscle-specific, mitochondrial disorder with onset in infancy. MC4DN18 is characterized by hypotonia, limb and facial muscle weakness, and high arched palate. Some patients have respiratory insufficiency at birth and cardiomyopathy. Patient skeletal muscle shows decreased levels and activity of mitochondrial respiratory complex IV.

OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 18mitochondrial complex IV deficiency, nuclear-type
HGNC:2279UniProt:Q02221
MT-CO2Cytochrome c oxidase subunit 2Candidate gene tested inDesconhecido
FUNÇÃO

Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (6)
Cytoprotection by HMOX1Respiratory electron transportTP53 Regulates Metabolic GenesComplex IV assemblyMitochondrial translation termination
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency

A disorder of the mitochondrial respiratory chain with heterogeneous clinical manifestations, ranging from isolated myopathy to severe multisystem disease affecting several tissues and organs. Features include hypertrophic cardiomyopathy, hepatomegaly and liver dysfunction, hypotonia, muscle weakness, exercise intolerance, developmental delay, delayed motor development and intellectual disability. Some affected individuals manifest a fatal hypertrophic cardiomyopathy resulting in neonatal death. A subset of patients manifest Leigh syndrome.

OUTRAS DOENÇAS (3)
mitochondrial diseaseMELAS syndromemitochondrial complex IV deficiency, nuclear-type
HGNC:7421UniProt:P00403
MT-CO1Cytochrome c oxidase subunit 1Candidate gene tested inDesconhecido
FUNÇÃO

Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (6)
Cytoprotection by HMOX1Respiratory electron transportTP53 Regulates Metabolic GenesComplex IV assemblyMitochondrial translation termination
MECANISMO DE DOENÇA

Leber hereditary optic neuropathy

A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

OUTRAS DOENÇAS (6)
mitochondrial diseaseMELAS syndromemitochondrial complex IV deficiency, nuclear-typemitochondrial non-syndromic sensorineural hearing loss
HGNC:7419UniProt:P00395
NDUFAF1Complex I intermediate-associated protein 30, mitochondrialCandidate gene tested inTolerante
FUNÇÃO

As part of the MCIA complex, involved in the assembly of the mitochondrial complex I

LOCALIZAÇÃO

MitochondrionMitochondrion matrix

VIAS BIOLÓGICAS (1)
Complex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 11

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN11 transmission pattern is consistent with autosomal recessive inheritance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
40.5 TPM
Glândula adrenal
37.7 TPM
Fibroblastos
34.5 TPM
Músculo esquelético
33.8 TPM
Linfócitos
28.3 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 11mitochondrial complex I deficiency
HGNC:18828UniProt:Q9Y375
FOXRED1FAD-dependent oxidoreductase domain-containing protein 1Candidate gene tested inTolerante
FUNÇÃO

Required for the assembly of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) (PubMed:20858599, PubMed:25678554). Involved in mid-late stages of complex I assembly (PubMed:25678554)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Complex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 19

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN19 transmission pattern is consistent with autosomal recessive inheritance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
53.0 TPM
Cerebelo
47.0 TPM
Linfócitos
41.9 TPM
Brain Frontal Cortex BA9
38.9 TPM
Córtex cerebral
34.7 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 19mitochondrial complex I deficiency
HGNC:26927UniProt:Q96CU9
COX8ACytochrome c oxidase subunit 8A, mitochondrialCandidate gene tested inTolerante
FUNÇÃO

Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (4)
Cytoprotection by HMOX1Respiratory electron transportTP53 Regulates Metabolic GenesComplex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 15

An autosomal recessive mitochondrial disorder with onset in infancy. MC4DN15 is characterized by global developmental delay, poor feeding, metabolic acidosis, short stature, microcephaly, proximal muscle weakness, and distal spasticity. Additional manifestations include scoliosis, primary pulmonary hypertension, refractory seizures, and inability to walk. Serum and CSF lactate levels are increased. Patient tissues show decreased levels and activity of mitochondrial respiratory complex IV.

OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 15mitochondrial complex IV deficiency, nuclear-type
HGNC:2294UniProt:P10176
COX14Cytochrome c oxidase assembly protein COX14Candidate gene tested inModerado
FUNÇÃO

Core component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly. Requires for coordination of the early steps of cytochrome c oxidase assembly with the synthesis of MT-CO1

LOCALIZAÇÃO

Mitochondrion outer membrane

VIAS BIOLÓGICAS (1)
Complex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 10

An autosomal recessive mitochondrial disorder that manifests with neonatal neurological and respiratory distress. Clinical features include facial dysmorphism, hypotelorism, microphthalmia, an ogival palate, and severe metabolic acidosis. Death occurs in early infancy. Autoptic examination reveals brain hypertrophy, diffuse alteration of white matter myelination, numerous cavities in the parieto-occipital region, brainstem and cerebellum, as well as hepatomegaly, hypertrophic cardiomyopathy, renal hypoplasia, and adrenal hyperplasia. Patient tissues show decreased levels and activity of mitochondrial respiratory complex IV.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 10mitochondrial complex IV deficiency, nuclear-type
HGNC:28216UniProt:Q96I36
COA3Cytochrome c oxidase assembly factor 3 homolog, mitochondrialCandidate gene tested inTolerante
FUNÇÃO

Core component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly. MITRAC complexes regulate both translation of mitochondrial encoded components and assembly of nuclear-encoded components imported in mitochondrion. Required for efficient translation of MT-CO1 and mitochondrial respiratory chain complex IV assembly

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Complex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 14

An autosomal recessive mitochondrial disorder with onset in early childhood. MC4DN14 is characterized by developmental delay, cognitive impairment, motor delay, abnormal gait, sensorimotor demyelinating polyneuropathy, exercise intolerance, obesity, and short stature. Serum lactate levels are marginally increased. Patient tissues show decreased levels and activity of mitochondrial respiratory complex IV.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 14mitochondrial complex IV deficiency, nuclear-type
HGNC:24990UniProt:Q9Y2R0
MT-ND2NADH-ubiquinone oxidoreductase chain 2Candidate gene tested inDesconhecido
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:16996290). Essential for the catalytic activity and assembly of complex I (PubMed:16996290)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (4)
Respiratory electron transportComplex I biogenesisMitochondrial translation terminationMitochondrial protein degradation
MECANISMO DE DOENÇA

Leber hereditary optic neuropathy

A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

OUTRAS DOENÇAS (4)
mitochondrial diseaseLeber hereditary optic neuropathymaternally-inherited Leigh syndromemitochondrial complex I deficiency
HGNC:7456UniProt:P03891
NDUFA6NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6Candidate gene tested inTolerante
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed to be not involved in catalysis. Required for proper complex I assembly (PubMed:30245030). Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 33

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN33 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
137.1 TPM
Músculo esquelético
122.6 TPM
Coração - Átrio
121.9 TPM
Rim - Medula
116.5 TPM
Esôfago - Muscular
101.6 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 33mitochondrial complex I deficiency
HGNC:7690UniProt:P56556
MT-ND3NADH-ubiquinone oxidoreductase chain 3Candidate gene tested inDesconhecido
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:25118196). Essential for the catalytic activity of complex I (PubMed:25118196)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (3)
Respiratory electron transportComplex I biogenesisMitochondrial translation termination
MECANISMO DE DOENÇA

Leigh syndrome

An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia.

OUTRAS DOENÇAS (4)
mitochondrial diseasematernally-inherited Leigh syndromeLeber plus diseasemitochondrial complex I deficiency
HGNC:7458UniProt:P03897
PET117Protein PET117 homolog, mitochondrialCandidate gene tested inTolerante
LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (1)
Complex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 19

An autosomal recessive mitochondrial disorder with onset in infancy or early childhood. MC4DN19 is characterized by global developmental delay, impaired intellectual development, developmental regression, loss of acquired motor and language skills, and motor dysfunction. Patient tissues show decreased levels and activity of mitochondrial respiratory complex IV.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Brain Frontal Cortex BA9
11.8 TPM
Pituitária
11.0 TPM
Cérebro - Hemisfério cerebelar
10.8 TPM
Glândula adrenal
10.4 TPM
Brain Spinal cord cervical c-1
10.0 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 19mitochondrial complex IV deficiency, nuclear-type
HGNC:40045UniProt:Q6UWS5
COX4I1Cytochrome c oxidase subunit 4 isoform 1, mitochondrialCandidate gene tested inTolerante
FUNÇÃO

Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (5)
Cytoprotection by HMOX1Respiratory electron transportTP53 Regulates Metabolic GenesComplex IV assemblyMitochondrial protein degradation
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 16

An autosomal recessive mitochondrial disorder with onset in infancy and variable manifestations. MC4DN16 features include feeding difficulties, poor overall growth, short stature, microcephaly, developmental regression, severe hypotonia, and seizures. Cerebral and cerebellar atrophy, and abnormal lesions in the basal ganglia can be observed on brain imaging. Patient tissues show decreased levels and activity of mitochondrial respiratory complex IV.

OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 16mitochondrial complex IV deficiency, nuclear-type
HGNC:2265UniProt:P13073
MT-CO3Cytochrome c oxidase subunit 3Candidate gene tested inDesconhecido
FUNÇÃO

Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (5)
Cytoprotection by HMOX1Respiratory electron transportTP53 Regulates Metabolic GenesComplex IV assemblyMitochondrial translation termination
MECANISMO DE DOENÇA

Leber hereditary optic neuropathy

A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

OUTRAS DOENÇAS (5)
mitochondrial diseasemitochondrial complex IV deficiency, nuclear-typeMELAS syndromehereditary recurrent myoglobinuria
HGNC:7422UniProt:P00414
MT-ND1NADH-ubiquinone oxidoreductase chain 1Candidate gene tested inDesconhecido
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:1959619). Essential for the catalytic activity and assembly of complex I (PubMed:1959619, PubMed:26929434)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (4)
Respiratory electron transportComplex I biogenesisMitochondrial translation terminationMitochondrial protein degradation
MECANISMO DE DOENÇA

Leber hereditary optic neuropathy

A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

OUTRAS DOENÇAS (5)
mitochondrial diseaseMELAS syndromemitochondrial complex I deficiencymaternally-inherited Leigh syndrome
HGNC:7455UniProt:P03886
UQCRBCytochrome b-c1 complex subunit 7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex III assembly
MECANISMO DE DOENÇA

Mitochondrial complex III deficiency, nuclear type 3

A disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. Clinical features include mitochondrial encephalopathy, psychomotor retardation, ataxia, severe failure to thrive, liver dysfunction, renal tubulopathy, muscle weakness and exercise intolerance.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Átrio
145.2 TPM
Coração - Ventrículo esquerdo
127.0 TPM
Cérebro - Hemisfério cerebelar
99.5 TPM
Músculo esquelético
96.7 TPM
Ovário
90.3 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex III deficiency nuclear type 3mitochondrial complex III deficiency
HGNC:12582UniProt:P14927
NDUFAF2NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as a molecular chaperone for mitochondrial complex I assembly (PubMed:16200211, PubMed:19384974). Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone (PubMed:16200211, PubMed:27626371). Is involved in the initial steps of cilia formation, including removal of CP110 from the mother centrioles, docking of membrane vesicles to the mother centrioles, and establishment of the transition z

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (1)
Complex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 10

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN10 transmission pattern is consistent with autosomal recessive inheritance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
65.3 TPM
Artéria tibial
46.5 TPM
Esôfago - Junção
43.4 TPM
Aorta
41.3 TPM
Esôfago - Muscular
41.3 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 10mitochondrial complex I deficiency
HGNC:28086UniProt:Q8N183
TACO1Translational activator of cytochrome c oxidase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as a translational activator of mitochondrially-encoded cytochrome c oxidase 1

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (1)
Complex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 8

An autosomal recessive mitochondrial disorder characterized by slowly progressive cognitive dysfunction, dystonia or visual impairment that appear after an uneventful early childhood. Additional features include gait difficulties, spasticity, dysarthria, hypotonia, and variable intellectual disability. Brain imaging shows white matter abnormalities in the basal ganglia. Serum lactate levels are increased. Patient tissues show decreased levels and activity of mitochondrial respiratory complex IV.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Fígado
49.2 TPM
Fibroblastos
41.6 TPM
Linfócitos
39.2 TPM
Músculo esquelético
35.6 TPM
Coração - Ventrículo esquerdo
31.6 TPM
OUTRAS DOENÇAS (1)
mitochondrial complex IV deficiency, nuclear type 8
HGNC:HGNC:24316UniProt:Q9BSH4
NDUFS6NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 9

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN9 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
98.6 TPM
Testículo
81.4 TPM
Músculo esquelético
79.3 TPM
Coração - Átrio
79.0 TPM
Linfócitos
70.1 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 9mitochondrial complex I deficiency
HGNC:7713UniProt:O75380
NDUFV2NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (Probable). Parts of the peripheral arm of the enzyme, where the electrons from NADH are accepted by flavin mononucleotide (FMN) and then passed along a chain of iron-sulfur clusters by electron tunnelling to the final acceptor ubiquinone (Probable). Contains one iron-sulfur cluster (Probabl

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 7

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN7 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
143.4 TPM
Linfócitos
138.2 TPM
Coração - Ventrículo esquerdo
111.4 TPM
Fígado
99.1 TPM
Glândula adrenal
86.0 TPM
OUTRAS DOENÇAS (3)
mitochondrial complex I deficiency, nuclear type 7mitochondrial complex I deficiencyprogressive cavitating leukoencephalopathy
HGNC:7717UniProt:P19404
NDUFAF8NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 8Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I, MT-ND1) (PubMed:27499296). Required to stabilize NDUFAF5 (PubMed:27499296)

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (1)
Complex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 34

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN34 transmission pattern is consistent with autosomal recessive inheritance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
57.6 TPM
Linfócitos
44.9 TPM
Brain Nucleus accumbens basal ganglia
44.3 TPM
Brain Caudate basal ganglia
39.5 TPM
Cérebro - Amígdala
38.1 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 34mitochondrial complex I deficiency
HGNC:33551UniProt:A1L188
TIMMDC1Complex I assembly factor TIMMDC1, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Chaperone protein involved in the assembly of the mitochondrial NADH:ubiquinone oxidoreductase complex (complex I). Participates in constructing the membrane arm of complex I

LOCALIZAÇÃO

Mitochondrion membrane

VIAS BIOLÓGICAS (1)
Complex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 31

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN31 transmission pattern is consistent with autosomal recessive inheritance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
106.4 TPM
Coração - Ventrículo esquerdo
89.2 TPM
Nervo tibial
83.8 TPM
Músculo esquelético
83.5 TPM
Tireoide
82.3 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 31mitochondrial complex I deficiency
HGNC:1321UniProt:Q9NPL8
NDUFA2NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (3)
Respiratory electron transportComplex I biogenesisMitochondrial protein degradation
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 13

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN13 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
83.4 TPM
Testículo
79.9 TPM
Glândula adrenal
70.5 TPM
Rim - Medula
66.5 TPM
Pituitária
61.6 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 13cystic leukoencephalopathy without megalencephaly
HGNC:7685UniProt:O43678
DNAJC30DnaJ homolog subfamily C member 30, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Mitochondrial protein enriched in neurons that acts as a regulator of mitochondrial respiration (By similarity). Associates with the ATP synthase complex and facilitates ATP synthesis (By similarity). May be a chaperone protein involved in the turnover of the subunits of mitochondrial complex I N-module. It facilitates the degradation of N-module subunits damaged by oxidative stress, and contributes to complex I functional efficiency (PubMed:33465056)

LOCALIZAÇÃO

Mitochondrion inner membrane

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
27.4 TPM
Pituitária
18.9 TPM
Glândula adrenal
18.8 TPM
Tireoide
18.3 TPM
Brain Frontal Cortex BA9
15.8 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (3)
Leber-like hereditary optic neuropathy, autosomal recessive 1Williams syndromeLeber hereditary optic neuropathy
HGNC:16410UniProt:Q96LL9
LYRM7Complex III assembly factor LYRM7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Assembly factor required for Rieske Fe-S protein UQCRFS1 incorporation into the cytochrome b-c1 (CIII) complex. Functions as a chaperone, binding to this subunit within the mitochondrial matrix and stabilizing it prior to its translocation and insertion into the late CIII dimeric intermediate within the mitochondrial inner membrane

LOCALIZAÇÃO

Mitochondrion matrix

VIAS BIOLÓGICAS (1)
Complex III assembly
MECANISMO DE DOENÇA

Mitochondrial complex III deficiency, nuclear type 8

A form of mitochondrial complex III deficiency, a disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. Clinical features include mitochondrial encephalopathy, psychomotor retardation, ataxia, severe failure to thrive, liver dysfunction, renal tubulopathy, muscle weakness and exercise intolerance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
17.7 TPM
Brain Frontal Cortex BA9
13.8 TPM
Testículo
12.7 TPM
Fibroblastos
11.8 TPM
Brain Spinal cord cervical c-1
11.5 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex III deficiency nuclear type 8mitochondrial complex III deficiency
HGNC:28072UniProt:Q5U5X0
UQCC2Ubiquinol-cytochrome c reductase complex assembly factor 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for the assembly of the ubiquinol-cytochrome c reductase complex (mitochondrial respiratory chain complex III or cytochrome b-c1 complex). Plays a role in the modulation of respiratory chain activities such as oxygen consumption and ATP production and via its modulation of the respiratory chain activity can regulate skeletal muscle differentiation and insulin secretion by pancreatic beta-cells. Involved in cytochrome b translation and/or stability

LOCALIZAÇÃO

Mitochondrion matrix, mitochondrion nucleoidMitochondrionMitochondrion intermembrane spaceMitochondrion matrixMitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Complex III assembly
MECANISMO DE DOENÇA

Mitochondrial complex III deficiency, nuclear type 7

A form of mitochondrial complex III deficiency, a disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. MC3DN7 is characterized by severe intrauterine growth retardation, neonatal lactic acidosis and renal tubular dysfunction. Additional clinical features include a dysmorphic facial appearance, delayed psychomotor development, autistic features, aggressive behavior, and mild sensorineural hearing loss.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
76.4 TPM
Coração - Átrio
54.8 TPM
Pituitária
54.1 TPM
Fibroblastos
53.5 TPM
Coração - Ventrículo esquerdo
48.2 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
mitochondrial complex III deficiency nuclear type 7mitochondrial complex III deficiency
HGNC:21237UniProt:Q9BRT2
CYC1Cytochrome c1, heme protein, mitochondrialDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex III assembly
MECANISMO DE DOENÇA

Mitochondrial complex III deficiency, nuclear type 6

An autosomal recessive disorder caused by mitochondrial dysfunction. It is characterized by onset in early childhood of episodic acute lactic acidosis, ketoacidosis, and insulin-responsive hyperglycemia, usually associated with infection. Laboratory studies show decreased activity of mitochondrial complex III. Psychomotor development is normal.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
365.1 TPM
Coração - Ventrículo esquerdo
350.9 TPM
Coração - Átrio
278.0 TPM
Linfócitos
274.0 TPM
Glândula adrenal
252.9 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex III deficiency nuclear type 6mitochondrial complex III deficiency
HGNC:2579UniProt:P08574
UQCRC2Cytochrome b-c1 complex subunit 2, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (3)
Respiratory electron transportComplex III assemblyMitochondrial protein degradation
MECANISMO DE DOENÇA

Mitochondrial complex III deficiency, nuclear type 5

A disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. Clinical features include mitochondrial encephalopathy, psychomotor retardation, ataxia, severe failure to thrive, liver dysfunction, renal tubulopathy, muscle weakness and exercise intolerance.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
245.0 TPM
Coração - Ventrículo esquerdo
227.3 TPM
Linfócitos
218.5 TPM
Coração - Átrio
189.2 TPM
Cólon transverso
159.7 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex III deficiency nuclear type 5mitochondrial complex III deficiency
HGNC:12586UniProt:P22695
TTC19Tetratricopeptide repeat protein 19, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for the preservation of the structural and functional integrity of mitochondrial respiratory complex III by allowing the physiological turnover of the Rieske protein UQCRFS1 (PubMed:21278747, PubMed:28673544). Involved in the clearance of UQCRFS1 N-terminal fragments, which are produced upon incorporation of UQCRFS1 into the complex III and whose presence is detrimental for its catalytic activity (PubMed:28673544)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Complex III assembly
MECANISMO DE DOENÇA

Mitochondrial complex III deficiency, nuclear type 2

A disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. Clinical features include mitochondrial encephalopathy, psychomotor retardation, ataxia, severe failure to thrive, liver dysfunction, renal tubulopathy, muscle weakness and exercise intolerance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
64.2 TPM
Cerebelo
56.0 TPM
Tireoide
43.2 TPM
Pituitária
43.2 TPM
Brain Frontal Cortex BA9
41.2 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
mitochondrial complex III deficiency nuclear type 2mitochondrial complex III deficiency
HGNC:26006UniProt:Q6DKK2
NDUFC2NADH dehydrogenase [ubiquinone] 1 subunit C2Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis but required for the complex assembly. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 36

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN36 is characterized by global developmental delay, hypotonia, and failure to thrive apparent from infancy or early childhood. Affected individuals usually do not acquire ambulation, show progressive spasticity, and have impaired intellectual development with absent speech. MC1DN36 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
98.4 TPM
Cérebro - Hemisfério cerebelar
97.6 TPM
Tireoide
95.0 TPM
Cerebelo
82.2 TPM
Brain Frontal Cortex BA9
75.2 TPM
OUTRAS DOENÇAS (1)
mitochondrial complex I deficiency, nuclear type 36
HGNC:HGNC:7706UniProt:O95298
NDUFB8NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (3)
Respiratory electron transportComplex I biogenesisMitochondrial protein import
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 32

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN32 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Frontal Cortex BA9
305.0 TPM
Brain Anterior cingulate cortex BA24
273.1 TPM
Cérebro - Hemisfério cerebelar
248.2 TPM
Córtex cerebral
247.5 TPM
Cerebelo
220.8 TPM
OUTRAS DOENÇAS (1)
mitochondrial complex I deficiency, nuclear type 32
HGNC:HGNC:7703UniProt:O95169
NDUFA13NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis (PubMed:27626371). Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone (PubMed:27626371). Involved in the interferon/all-trans-retinoic acid (IFN/RA) induced cell death. This apoptotic activity is inhibited by interaction with viral IRF1. Preve

LOCALIZAÇÃO

Mitochondrion inner membraneNucleus

VIAS BIOLÓGICAS (3)
Respiratory electron transportComplex I biogenesisMitochondrial protein degradation
MECANISMO DE DOENÇA

Hurthle cell thyroid carcinoma

A rare type of thyroid cancer accounting for only about 3-10% of all differentiated thyroid cancers. These neoplasms are considered a variant of follicular carcinoma of the thyroid and are referred to as follicular carcinoma, oxyphilic type.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
261.5 TPM
Coração - Ventrículo esquerdo
190.8 TPM
Coração - Átrio
181.5 TPM
Pituitária
162.4 TPM
Brain Frontal Cortex BA9
149.7 TPM
OUTRAS DOENÇAS (3)
mitochondrial complex I deficiency, nuclear type 28differentiated thyroid carcinomathyroid Hurthle cell carcinoma
HGNC:17194UniProt:Q9P0J0
NDUFAF5Arginine-hydroxylase NDUFAF5, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Arginine hydroxylase that mediates hydroxylation of 'Arg-111' of NDUFS7 and is involved in the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I, MT-ND1) at early stages (PubMed:18940309, PubMed:27226634). May also have methyltransferase activity (Probable)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Complex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 16

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN16 transmission pattern is consistent with autosomal recessive inheritance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
12.2 TPM
Cerebelo
10.6 TPM
Testículo
8.1 TPM
Brain Frontal Cortex BA9
7.5 TPM
Nervo tibial
6.9 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 16mitochondrial complex I deficiency
HGNC:15899UniProt:Q5TEU4
NDUFS1NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:30879903, PubMed:31557978). Essential for catalysing the entry and efficient transfer of electrons within complex I (PubMed:31557978). Plays a key role in the assembly and stability of complex I and participates in the association of complex I with ubiquinol-cytochrome reductase comp

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (3)
Respiratory electron transportComplex I biogenesisMitochondrial protein degradation
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 5

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN5 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
50.6 TPM
Coração - Ventrículo esquerdo
42.4 TPM
Glândula adrenal
32.1 TPM
Coração - Átrio
31.0 TPM
Linfócitos
24.8 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 5mitochondrial complex I deficiency
HGNC:7707UniProt:P28331
NDUFB3NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 25

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN25 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
145.0 TPM
Linfócitos
128.5 TPM
Coração - Átrio
121.7 TPM
Músculo esquelético
120.4 TPM
Rim - Medula
112.7 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 25mitochondrial complex I deficiency
HGNC:7698UniProt:O43676
NDUFAF3NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Essential factor for the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I)

LOCALIZAÇÃO

NucleusMitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Complex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 18

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN18 transmission pattern is consistent with autosomal recessive inheritance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
486.2 TPM
Pituitária
112.6 TPM
Glândula adrenal
98.1 TPM
Tireoide
95.2 TPM
Brain Spinal cord cervical c-1
91.9 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 18mitochondrial complex I deficiency
HGNC:29918UniProt:Q9BU61
NDUFAF4NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I) (PubMed:18179882, PubMed:28853723). May be involved in cell proliferation and survival of hormone-dependent tumor cells. May be a regulator of breast tumor cell invasion

LOCALIZAÇÃO

MitochondrionMembrane

VIAS BIOLÓGICAS (1)
Complex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 15

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN15 transmission pattern is consistent with autosomal recessive inheritance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Brain Frontal Cortex BA9
31.3 TPM
Cérebro - Hemisfério cerebelar
30.8 TPM
Cerebelo
24.3 TPM
Coração - Ventrículo esquerdo
20.0 TPM
Coração - Átrio
20.0 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 15mitochondrial complex I deficiency
HGNC:21034UniProt:Q9P032
NDUFS4NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 1

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
120.3 TPM
Artéria tibial
118.1 TPM
Fibroblastos
115.8 TPM
Ovário
114.4 TPM
Nervo tibial
104.8 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 1mitochondrial complex I deficiency
HGNC:7711UniProt:O43181
COX16Cytochrome c oxidase assembly protein COX16 homolog, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for the assembly of the mitochondrial respiratory chain complex IV (CIV), also known as cytochrome c oxidase (PubMed:29355485, PubMed:29381136, PubMed:33169484). Promotes the insertion of copper into the active site of cytochrome c oxidase subunit II (MT-CO2/COX2) (PubMed:29355485, PubMed:29381136). Interacts specifically with newly synthesized MT-CO2/COX and its copper center-forming metallochaperones SCO1, SCO2 and COA6 (PubMed:29381136). Probably facilitates MT-CO2/COX2 association w

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Complex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 22

An autosomal recessive mitochondrial disorder characterized by hypertrophic cardiomyopathy, encephalopathy, fatal lactic acidosis, and isolated complex IV deficiency.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 22mitochondrial complex IV deficiency, nuclear-type
HGNC:20213UniProt:Q9P0S2
BCS1LMitochondrial chaperone BCS1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Chaperone necessary for the incorporation of Rieske iron-sulfur protein UQCRFS1 into the mitochondrial respiratory chain complex III (PubMed:11528392, PubMed:9878253). Plays an important role in the maintenance of mitochondrial tubular networks, respiratory chain assembly and formation of the LETM1 complex (PubMed:18628306)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Complex III assembly
MECANISMO DE DOENÇA

GRACILE syndrome

GRACILE stands for 'growth retardation, aminoaciduria, cholestasis, iron overload, lactic acidosis, and early death'. It is a recessively inherited lethal disease characterized by fetal growth retardation, lactic acidosis, aminoaciduria, cholestasis, and abnormalities in iron metabolism.

OUTRAS DOENÇAS (5)
mitochondrial complex III deficiency nuclear type 1GRACILE syndromeBjornstad syndromerenal tubulopathy-encephalopathy-liver failure syndrome
HGNC:1020UniProt:Q9Y276
NDUFA9NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Required for proper complex I assembly (PubMed:28671271). Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

LOCALIZAÇÃO

Mitochondrion matrix

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 26

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN26 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
25.2 TPM
Coração - Ventrículo esquerdo
24.6 TPM
Músculo esquelético
24.5 TPM
Cérebro - Hemisfério cerebelar
21.7 TPM
Cerebelo
17.5 TPM
OUTRAS DOENÇAS (1)
mitochondrial complex I deficiency, nuclear type 26
HGNC:HGNC:7693UniProt:Q16795
NDUFA11NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 14

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN14 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
59.6 TPM
Coração - Átrio
58.8 TPM
Cólon sigmoide
58.4 TPM
Útero
57.8 TPM
Próstata
56.3 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 14mitochondrial complex I deficiency
HGNC:20371UniProt:Q86Y39
ATP5F1EATP synthase F(1) complex subunit epsilon, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Subunit epsilon, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (PubMed:37244256). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating i

LOCALIZAÇÃO

MitochondrionMitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Formation of ATP by chemiosmotic couplingCristae formation
MECANISMO DE DOENÇA

Mitochondrial complex V deficiency, nuclear type 3

A mitochondrial disorder with heterogeneous clinical manifestations including dysmorphic features, psychomotor retardation, hypotonia, growth retardation, cardiomyopathy, enlarged liver, hypoplastic kidneys and elevated lactate levels in urine, plasma and cerebrospinal fluid.

OUTRAS DOENÇAS (2)
mitochondrial complex V (ATP synthase) deficiency, nuclear type 3mitochondrial proton-transporting ATP synthase complex deficiency
HGNC:838UniProt:P56381
COX11Cytochrome c oxidase assembly protein COX11, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Assembly factor for cytochrome c oxidase (respiratory chain complex IV, CIV) (PubMed:35750769). Probably acts as a metallochaperone that delivers copper to the copper B site of COX1 (PubMed:35750769)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Complex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 23

A primary mitochondrial disease, a clinically heterogeneous group of disorders arising from dysfunction of the mitochondrial respiratory chain. MC4DN23 is an autosomal recessive form characterized by infantile-onset encephalopathy. Clinical features include brain atrophy, severe developmental delay, seizures, and dyskinetic movement abnormalities.

VIAS REACTOME (1)
OUTRAS DOENÇAS (1)
mitochondrial complex IV deficiency, nuclear type 23
HGNC:HGNC:2261UniProt:Q9Y6N1
COX5ACytochrome c oxidase subunit 5A, mitochondrialDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (5)
Cytoprotection by HMOX1Respiratory electron transportTP53 Regulates Metabolic GenesComplex IV assemblyMitochondrial protein degradation
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 20

An autosomal recessive mitochondrial disorder with onset in early infancy. MC4DN20 is characterized by pulmonary arterial hypertension, poor feeding, failure to thrive, hypotonia, delayed development, increased serum lactate and metabolic acidosis. Death in infancy occurs due to cardiorespiratory failure. Patient tissues show variably decreased levels and activity of mitochondrial respiratory complex IV.

OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 20mitochondrial complex IV deficiency, nuclear-type
HGNC:2267UniProt:P20674
NDUFV1NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:28844695). Part of the peripheral arm of the enzyme, where the electrons from NADH are accepted by flavin mononucleotide (FMN) and then passed along a chain of iron-sulfur clusters by electron tunnelling to the final acceptor ubiquinone (PubMed:28844695). Contains FMN, which is the i

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (3)
Respiratory electron transportComplex I biogenesisMitochondrial protein degradation
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 4

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN4 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
240.6 TPM
Coração - Ventrículo esquerdo
236.3 TPM
Linfócitos
234.0 TPM
Cerebelo
233.0 TPM
Músculo esquelético
222.6 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 4mitochondrial complex I deficiency
HGNC:7716UniProt:P49821
TMEM70Transmembrane protein 70, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Scaffold protein that participates in the c-ring assembly of mitochondrial ATP synthase (F(1)F(0) ATP synthase or complex V) by facilitating the membrane insertion and oligomer formation of the subunit c/ATP5MC1 through its interaction (PubMed:31652072, PubMed:32275929, PubMed:33359711, PubMed:33753518). Therefore, participates in the early stage of mitochondrial ATP synthase biogenesis and also protects subunit c/ATP5MC1 against intramitochondrial proteolysis (PubMed:18953340, PubMed:20937241,

LOCALIZAÇÃO

Mitochondrion inner membrane

MECANISMO DE DOENÇA

Mitochondrial complex V deficiency, nuclear type 2

A mitochondrial disorder with heterogeneous clinical manifestations including dysmorphic features, psychomotor retardation, hypotonia, growth retardation, cardiomyopathy, enlarged liver, hypoplastic kidneys and elevated lactate levels in urine, plasma and cerebrospinal fluid.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
54.5 TPM
Linfócitos
32.1 TPM
Glândula adrenal
29.1 TPM
Brain Frontal Cortex BA9
28.8 TPM
Adipose Visceral Omentum
26.8 TPM
OUTRAS DOENÇAS (1)
mitochondrial complex V (ATP synthase) deficiency, nuclear type 2
HGNC:26050UniProt:Q9BUB7
COX20Cytochrome c oxidase assembly protein COX20, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Essential for the assembly of the mitochondrial respiratory chain complex IV (CIV), also known as cytochrome c oxidase (PubMed:23125284). Acts as a chaperone in the early steps of cytochrome c oxidase subunit II (MT-CO2/COX2) maturation, stabilizing the newly synthesized protein and presenting it to metallochaperones SCO1/2 which in turn facilitates the incorporation of the mature MT-CO2/COX2 into the assembling CIV holoenzyme (PubMed:24403053)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Complex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 11

An autosomal recessive mitochondrial disorder with onset in childhood or adolescence. MC4DN11 is characterized by walking difficulties, cerebellar ataxia, dystonia, choreoathetotic movements and dysarthria. Additional features may include sensory axonal neuropathy, cerebellar atrophy, and mild speech delay. Cognitive function is normal. Serum lactate levels are increased. Patient tissues show decreased levels and activity of mitochondrial respiratory complex IV.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 11mitochondrial complex IV deficiency, nuclear-type
HGNC:26970UniProt:Q5RI15
NDUFS3NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:14729820, PubMed:30140060). Essential for the catalytic activity and assembly of complex I (PubMed:14729820, PubMed:24028823, PubMed:30140060)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (3)
Respiratory electron transportComplex I biogenesisMitochondrial protein degradation
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 8

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN8 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
78.6 TPM
Cérebro - Hemisfério cerebelar
77.7 TPM
Brain Caudate basal ganglia
72.3 TPM
Brain Putamen basal ganglia
68.8 TPM
Brain Frontal Cortex BA9
68.7 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 8mitochondrial complex I deficiency
HGNC:7710UniProt:O75489
TMEM126BComplex I assembly factor TMEM126B, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

As part of the MCIA complex, involved in the assembly of the mitochondrial complex I (PubMed:27374773, PubMed:27374774, PubMed:32320651). Participates in constructing the membrane arm of complex I (PubMed:24191001)

LOCALIZAÇÃO

Mitochondrion membrane

VIAS BIOLÓGICAS (1)
Complex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 29

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN29 transmission pattern is consistent with autosomal recessive inheritance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
44.8 TPM
Útero
40.8 TPM
Nervo tibial
40.0 TPM
Cervix Endocervix
38.4 TPM
Fibroblastos
38.0 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 29mitochondrial complex I deficiency
HGNC:30883UniProt:Q8IUX1
MTFMTMethionyl-tRNA formyltransferase, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Methionyl-tRNA formyltransferase that formylates methionyl-tRNA in mitochondria and is crucial for translation initiation

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (1)
Mitochondrial translation initiation
MECANISMO DE DOENÇA

Combined oxidative phosphorylation deficiency 15

An autosomal recessive, mitochondrial, neurologic disorder characterized by features of Leigh syndrome and combined oxidative phosphorylation deficiency. Clinical features include mild global developmental delay, white matter abnormalities, ataxia, incoordination, speech and reading difficulties, T2-weighted hyperintensities in the basal ganglia, corpus callosum, and brainstem.

EXPRESSÃO TECIDUAL(Ubíquo)
Útero
12.8 TPM
Fallopian Tube
12.8 TPM
Cervix Endocervix
12.1 TPM
Cervix Ectocervix
11.7 TPM
Cérebro - Hemisfério cerebelar
11.6 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 27combined oxidative phosphorylation defect type 15
HGNC:29666UniProt:Q96DP5
NDUFA1NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1Disease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 12

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
754.6 TPM
Coração - Átrio
614.2 TPM
Rim - Medula
479.1 TPM
Músculo esquelético
469.9 TPM
Linfócitos
453.6 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 12mitochondrial complex I deficiency
HGNC:7683UniProt:O15239
ATP5F1DATP synthase F(1) complex subunit delta, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Subunit delta, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (Probable) (PubMed:37244256). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk r

LOCALIZAÇÃO

MitochondrionMitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Formation of ATP by chemiosmotic couplingCristae formation
MECANISMO DE DOENÇA

Mitochondrial complex V deficiency, nuclear type 5

A mitochondrial disorder characterized by childhood onset of episodic metabolic decompensation featuring lactic acidosis and hyperammonemia accompanied by ketoacidosis or hypoglycemia. Chronic manifestations include developmental delay, easy fatiguability, and 3-methylglutaconic aciduria. The transmission pattern of MC5DN5 is consistent with autosomal recessive inheritance.

OUTRAS DOENÇAS (2)
mitochondrial complex V (ATP synthase) deficiency, nuclear type 5mitochondrial proton-transporting ATP synthase complex deficiency
HGNC:837UniProt:P30049
UQCRQCytochrome b-c1 complex subunit 8Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (3)
Respiratory electron transportComplex III assemblyMitochondrial protein degradation
MECANISMO DE DOENÇA

Mitochondrial complex III deficiency, nuclear type 4

A disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. Clinical features include mitochondrial encephalopathy, psychomotor retardation, ataxia, severe failure to thrive, liver dysfunction, renal tubulopathy, muscle weakness and exercise intolerance.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
368.3 TPM
Músculo esquelético
306.8 TPM
Fígado
286.8 TPM
Coração - Átrio
284.2 TPM
Fibroblastos
237.5 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex III deficiency nuclear type 4mitochondrial complex III deficiency
HGNC:29594UniProt:O14949
UQCRFS1Cytochrome b-c1 complex subunit Rieske, mitochondrialDisease-causing germline mutation(s) inModerado
FUNÇÃO

Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation (PubMed:31883641). The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succi

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Complex III assembly
MECANISMO DE DOENÇA

Mitochondrial complex III deficiency, nuclear type 10

A form of mitochondrial complex III deficiency, a disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. MC3DN10 is an autosomal recessive form characterized by fetal bradycardia, poor feeding, hypotonia, hypertrophic cardiomyopathy, alopecia totalis, low mitochondrial complex III activity and lactic acidosis.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
133.8 TPM
Coração - Ventrículo esquerdo
102.0 TPM
Coração - Átrio
86.6 TPM
Rim - Medula
78.3 TPM
Linfócitos
76.4 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex III deficiency, nuclear type 10mitochondrial complex III deficiency
HGNC:12587UniProt:P47985
NDUFS7NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrialDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:17275378). Essential for the catalytic activity of complex I (PubMed:17275378)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 3

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN3 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
88.0 TPM
Cérebro - Hemisfério cerebelar
84.6 TPM
Cerebelo
84.0 TPM
Testículo
68.2 TPM
Coração - Ventrículo esquerdo
64.3 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 3mitochondrial complex I deficiency
HGNC:7714UniProt:O75251
NDUFA10NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone

LOCALIZAÇÃO

Mitochondrion matrix

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 22

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN22 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
95.5 TPM
Cerebelo
92.4 TPM
Nervo tibial
52.4 TPM
Coração - Ventrículo esquerdo
50.1 TPM
Linfócitos
47.7 TPM
OUTRAS DOENÇAS (1)
mitochondrial complex I deficiency, nuclear type 22
HGNC:HGNC:7684UniProt:O95299
NUBPLIron-sulfur cluster transfer protein NUBPLDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Iron-sulfur cluster transfer protein involved in the assembly of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) (PubMed:19752196). May deliver one or more Fe-S clusters to complex I subunits (PubMed:19752196)

LOCALIZAÇÃO

Mitochondrion

VIAS BIOLÓGICAS (1)
Complex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 21

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN21 transmission pattern is consistent with autosomal recessive inheritance.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
10.0 TPM
Ovário
7.6 TPM
Nervo tibial
7.4 TPM
Linfócitos
7.3 TPM
Tecido adiposo
7.0 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 21mitochondrial complex I deficiency
HGNC:20278UniProt:Q8TB37
NDUFS8NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:22499348). Essential for the catalytic activity and assembly of complex I (PubMed:22499348)

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 2

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN2 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
151.7 TPM
Coração - Ventrículo esquerdo
104.0 TPM
Coração - Átrio
101.5 TPM
Músculo esquelético
94.8 TPM
Pituitária
93.8 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex I deficiency, nuclear type 2mitochondrial complex I deficiency
HGNC:7715UniProt:O00217
COX6B1Cytochrome c oxidase subunit 6B1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (4)
Cytoprotection by HMOX1Respiratory electron transportTP53 Regulates Metabolic GenesComplex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 7

An autosomal recessive mitochondrial disorder characterized by encephalomyopathy resulting in variable clinical manifestations. Features include muscle weakness, gait disturbances, neurodegeneration, cognitive decline, metabolic acidosis, feeding difficulties, poor overall growth, cortical visual impairment, and hypertrophic cardiomyopathy. Serum lactate levels are increased. Patient tissues show decreased levels and activity of mitochondrial respiratory complex IV.

OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 7mitochondrial complex IV deficiency, nuclear-type
HGNC:2280UniProt:P14854
COX10Protoheme IX farnesyltransferase, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Converts protoheme IX and farnesyl diphosphate to heme O

LOCALIZAÇÃO

Mitochondrion membrane

VIAS BIOLÓGICAS (1)
Heme biosynthesis
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 3

An autosomal recessive mitochondrial disorder characterized by cytochrome c oxidase deficiency. Clinical features include muscle weakness, hypotonia, ataxia, ptosis, metabolic acidosis, poor feeding, delayed motor development, anemia, sensorineural hearing loss, and cardiomyopathy.

VIAS REACTOME (1)
OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 3mitochondrial complex IV deficiency, nuclear-type
HGNC:2260UniProt:Q12887
SURF1Surfeit locus protein 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (1)
Complex IV assembly
MECANISMO DE DOENÇA

Mitochondrial complex IV deficiency, nuclear type 1

An autosomal recessive disorder of the mitochondrial respiratory chain characterized by early-onset, rapidly progressive encephalopathy, neurodegeneration, and loss of motor and cognitive skills. Affected individuals show hypotonia, failure to thrive, loss of the ability to sit or walk, poor communication, poor eye contact, oculomotor abnormalities, as well as deafness, ataxia, tremor, and brisk tendon reflexes. Brain imaging shows bilateral symmetric lesions in the basal ganglia. Lactate levels in serum and cerebrospinal fluid are increased. Patient tissues show decreased levels and activity of mitochondrial respiratory complex IV. Death in childhood may occur, often due to central respiratory failure.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Tireoide
67.2 TPM
Artéria tibial
65.0 TPM
Aorta
63.9 TPM
Cólon sigmoide
62.4 TPM
Esôfago - Junção
60.0 TPM
OUTRAS DOENÇAS (2)
mitochondrial complex IV deficiency, nuclear type 1Charcot-Marie-Tooth disease type 4K
HGNC:11474UniProt:Q15526
NDUFS2NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:22036843, PubMed:28031252, PubMed:30922174). Essential for the catalytic activity of complex I (PubMed:22036843, PubMed:30922174). Essential for the assembly of complex I (By similarity). Redox-sensitive, critical component of the oxygen-sensing pathway in the pulmonary vasculature w

LOCALIZAÇÃO

Mitochondrion inner membrane

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 6

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN6 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Músculo esquelético
154.5 TPM
Ovário
130.0 TPM
Cérebro - Hemisfério cerebelar
124.7 TPM
Coração - Ventrículo esquerdo
120.8 TPM
Cerebelo
120.6 TPM
OUTRAS DOENÇAS (4)
mitochondrial complex I deficiency, nuclear type 6Leber-like hereditary optic neuropathy, autosomal recessive 2mitochondrial complex I deficiencyLeber hereditary optic neuropathy
HGNC:7708UniProt:O75306
NDUFA8NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis (PubMed:27626371, PubMed:32385911, PubMed:33153867). Complex I functions in the transfer of electrons from NADH to the respiratory chain (PubMed:27626371). The immediate electron acceptor for the enzyme is believed to be ubiquinone (PubMed:27626371)

LOCALIZAÇÃO

Mitochondrion inner membraneMitochondrion intermembrane spaceMitochondrion

VIAS BIOLÓGICAS (2)
Respiratory electron transportComplex I biogenesis
MECANISMO DE DOENÇA

Mitochondrial complex I deficiency, nuclear type 37

A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN37 features include developmental delay, cerebral atrophy, epilepsy, growth retardation, congenital myopathy with disproportion of fibers, and severely decreased activity of complex I. MC1DN37 transmission pattern is consistent with autosomal recessive inheritance.

EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
220.3 TPM
Coração - Átrio
208.0 TPM
Testículo
204.3 TPM
Brain Frontal Cortex BA9
172.0 TPM
Cólon sigmoide
162.4 TPM
OUTRAS DOENÇAS (1)
mitochondrial complex I deficiency, nuclear type 37
HGNC:HGNC:7692UniProt:P51970

Variantes genéticas (ClinVar)

182 variantes patogênicas registradas no ClinVar.

🧬 NDUFAF6: NM_001354514.2(NDUFAF6):c.-83-7036G>A ()
🧬 NDUFAF6: NM_152416.4(NDUFAF6):c.110_111del (p.Pro37fs) ()
🧬 NDUFAF6: NM_152416.4(NDUFAF6):c.581-1G>A ()
🧬 NDUFAF6: NM_152416.4(NDUFAF6):c.395A>G (p.Gln132Arg) ()
🧬 NDUFAF6: NM_152416.4(NDUFAF6):c.648C>A (p.Cys216Ter) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença isolada do complexo da fosforilação oxidativa

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Screening strategy using a filamentous fungus model to repurpose drugs for mitochondrial complex I deficiencies.

Life sciences2026 Apr 01

This study aimed to repurpose FDA-approved drugs for the treatment of mitochondrial complex I diseases. The NUO-51 protein of the filamentous fungus Podospora anserina is the homolog of the human key catalytic subunit of complex I, NDUFV1. By introducing a pathogenic mutation into P. anserina NUO-51 we created a novel model of complex I deficiency targeting the NDUFV1 subunit. The thermosensitive phenotype of the fungal mutant enabled us to screen a library of nearly one thousand FDA-approved molecules. We have implemented various techniques such as growth analysis, oxygen consumption measurements, complex I activity assays and western blotting on Podospora, Caenorhabditis elegans and human on equivalent NDUFV1 mutant models, treated or untreated with the most effective drugs found during the screen. We isolated a series of compounds able to rescue the growth defect of the Podospora nuo-51 mutant, including ligands of serotonin receptors or transporters. Among the selected drugs, alverine citrate (ALV) and dapoxetine hydrochloride (DAP) emerged as the most active drugs. Both drugs enhanced respiration and complex I activity, not only in the Podospora mutant, but also in Caenorhabditis elegans worms deficient for the NDUFV1 ortholog and in fibroblasts from patient carrying NDUFV1 mutations. Together, our work demonstrates the usefulness of Podospora anserina as fungal model for identifying promising therapeutic candidates for complex I diseases, paving the way for future clinical trials.

#2

Structural basis for late maturation steps of mitochondrial respiratory chain complex IV within the human respirasome.

Nature communications2026 Jan 10

The mitochondrial respiratory chain comprises four multimeric complexes (CI-CIV) that drive oxidative phosphorylation by transferring electrons to oxygen and generating the proton gradient required for ATP synthesis. These complexes can associate into supercomplexes (SCs), such as the CI + CIII₂ + CIV respirasome, but how SCs form, by joining preassembled complexes or by engaging partially assembled intermediates, remains unresolved. Here, we use cryo-electron microscopy to determine high-resolution structures of native human CI + CIII₂ + CIV late-assembly intermediates. Together with biochemical analyses, these structures show that respirasome biogenesis concludes with the final maturation of CIV while it is associated with fully assembled CI and CIII₂. We identify HIGD2A as a placeholder factor within isolated and supercomplexed CIV that is replaced by subunit NDUFA4 during the last step of CIV and respirasome assembly. This mechanism suggests that placeholders such as HIGD2A act as molecular timers, preventing premature incorporation of NDUFA4 or its isoforms and ensuring the orderly progression of pre-SC particles into functional respirasomes. Since defects in CIV assembly, including NDUFA4 deficiencies, cause severe encephalomyopathies and neurodegenerative disorders, understanding the molecular architecture and assembly pathways of isolated and supercomplexed CIV offers insight into the pathogenic mechanisms underlying these conditions.

#3

Elamipretide Improves Mitochondrial Function in Mitochondrial Trifunctional Protein-Deficient Mice and Human Fibroblasts.

Journal of inherited metabolic disease2026 Jan

Mitochondrial trifunctional protein (TFP) deficiency is an inherited disorder of long-chain fatty acid β-oxidation (FAO). TFP is a heteromeric enzyme composed of two α and two β-subunits. Despite early detection and dietary treatment, TFP deficiency patients often develop hypoglycemia, rhabdomyolysis, cardiomyopathy, and peripheral neuropathy. Degenerative retinopathy and milder peripheral neuropathy occur in patients with an isolated deficiency of the αTFP subunit of long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) activity. Triheptanoin treatment improves most complications, but not peripheral neuropathy and retinopathy. Notably, TFP also carries a fourth enzymatic function involved in cardiolipin remodeling, which we previously found to be impaired in TFP/LCHAD deficiency. We therefore tested whether elamipretide, a synthetic cardiolipin-binding peptide, could improve mitochondrial function and cardiolipin levels in βTFP-deficient mice and patient-derived fibroblasts. Mice were treated with elamipretide delivered by osmotic minipump and challenged with treadmill exercise or cold stress after fasting. βTFP-deficient mice treated with elamipretide showed improved exercise endurance, but cold tolerance was not altered. Liver mitochondria from male βTFP-deficient mice demonstrated improved FAO-ETC enzyme activities. However, cardiolipin content and composition were unchanged. In patient fibroblasts, elamipretide produced a possible genotype-dependent increase in mitochondrial bioenergetics and a reduction in ROS. These results support a mechanism in which elamipretide stabilizes between FAO enzymes and ETC complexes, thereby improving mitochondrial function independently of changes in cardiolipin levels. Elamipretide thus emerges as a potential therapeutic agent for TFP/LCHAD deficiency, warranting further preclinical studies.

#4

Immune Cell Mitochondrial Phenotypes Are Largely Preserved in Mitochondrial Diseases and Do Not Reflect Disease Severity.

Neurology. Genetics2026 Feb

The aim of this study was to profile immune cell mitochondrial phenotypes in mitochondrial diseases (MitoD) and evaluate how these phenotypes relate to disease manifestations or biomarkers. We profiled mitochondrial content and oxidative phosphorylation (OxPhos) enzymatic activities in isolated monocytes, lymphocytes, neutrophils, platelets, and mixed peripheral blood mononuclear cells (PBMCs) from 37 individuals with MitoD (m.3243A > G, n = 23; single, large-scale mitochondrial DNA (mtDNA) deletions, n = 14) and 68 healthy women and men from the Mitochondrial Stress, Brain Imaging, and Epigenetics study. We first confirmed and quantified robust cell type differences in mitochondrial content; activities of OxPhos complexes I, II, and IV; and the mitochondrial respiratory capacity (MRC) index. In relation to MitoD, neither mitochondrial content nor OxPhos capacity was consistently affected, other than a mild monocyte-specific reduction in complex I (partially mtDNA encoded) relative to complex II (entirely nDNA encoded), consistent with the mtDNA defects examined. Relative to the large differences in cell type-specific mitochondrial phenotypes, differences in MitoD relative to controls were generally small (<25%) across mitochondrial measures. MitoD biomarkers growth differentiation factor 15 and fibroblast growth factor 21, as well as clinical disease severity measures, were most strongly related to mitochondrial abnormalities in platelets, and most weakly related to mitochondrial OxPhos capacity in lymphocytes, which are known to eliminate mtDNA defects. Finally, comparing PBMCs collected in the morning/fasted state with those in the afternoon/fed state after a stressful experience, we report significant time-dependent changes in mitochondrial biology over hours. Overall, these results demonstrate that the dynamic and cell type-specific mitochondrial phenotypes are preserved in MitoD and are generally unrelated to symptom severity.

#5

Bmal1 regulates thermogenic function by modulation of lipolytic and OXPHOS gene expression in male mice brown adipocytes.

Endocrinology2026 Feb 26

The circadian clock plays a critical role in coordinating energy metabolism across tissues, including brown adipose tissue (BAT), a major site of nonshivering thermogenesis. This study aimed to elucidate the cell-autonomous role of the peripheral circadian clock in brown adipocyte thermogenesis using an in vitro model independent of extrinsic cues. Primary brown adipocytes were differentiated from the stromal vascular fraction of interscapular BAT isolated from C57BL/6J mice. An in vitro model of BAT clock disruption was established by siRNA-mediated knockdown of the core clock gene Bmal1. Thermogenic function was assessed via measurement of oxygen consumption rate (OCR) using an extracellular flux analyzer. To further assess the thermogenic process, protein expression levels of lipolytic enzymes and mitochondrial oxidative phosphorylation (OXPHOS) complexes were analyzed by Western blotting. Bmal1-knockdown markedly reduced both basal and β-adrenergic-stimulated OCR, indicating impaired thermogenic function, despite comparable cellular differentiation, preserved β-adrenergic responsiveness, and elevated uncoupling protein 1 (Ucp1) expression. Notably, Bmal1-deficient cells exhibited decreased protein expression of key lipolytic enzymes, adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL), as well as multiple mitochondrial oxidative phosphorylation (OXPHOS) subunits, suggesting decreased free fatty acid supply and reduced mitochondrial ability to generate the proton gradient required for UCP1-mediated thermogenesis. The peripheral circadian clock in brown adipocytes supports thermogenic function by regulating lipid mobilization and mitochondrial oxidative function, thus its disruption may lead to decreased energy expenditure and increased susceptibility to metabolic disorders.

📚 EuropePMCmostrando 199

2026

Bmal1 regulates thermogenic function by modulation of lipolytic and OXPHOS gene expression in male mice brown adipocytes.

Endocrinology
2026

Paenibacillus polymyxa K17 Controls Leaf Spot of Tea Plant by Impairing Fungal Cellular Structure and Energy Metabolism.

Journal of agricultural and food chemistry
2026

Screening strategy using a filamentous fungus model to repurpose drugs for mitochondrial complex I deficiencies.

Life sciences
2026

Structural basis for late maturation steps of mitochondrial respiratory chain complex IV within the human respirasome.

Nature communications
2026

Elamipretide Improves Mitochondrial Function in Mitochondrial Trifunctional Protein-Deficient Mice and Human Fibroblasts.

Journal of inherited metabolic disease
2026

Immune Cell Mitochondrial Phenotypes Are Largely Preserved in Mitochondrial Diseases and Do Not Reflect Disease Severity.

Neurology. Genetics
2026

Mitochondrial Metabolic Reprogramming of Cortical Neurons by Prenatal Exposure to Corticosterone: A Shift from ATP Synthesis to Membrane Potential Maintenance.

Experimental neurobiology
2025

Clinical utility of the ATP hydrolysis assay for the diagnosis of complex V deficiency in cultured skin fibroblasts.

Molecular genetics and metabolism
2025

Geographic containment and virulence-resistance trade-offs drive the evolution of hypervirulent Klebsiella pneumoniae.

iMeta
2025

Sex dimorphism and substrate dependency of liver mitochondrial bioenergetics and H2O2 production.

American journal of physiology. Gastrointestinal and liver physiology
2025

Sex Differences in Renal Mitochondrial Respiration and H2O2 Emission in Young Dahl Salt-Sensitive Rats.

Function (Oxford, England)
2025

Gene therapy and mRNA drugs approach for mitochondrial OXPHOS deficiencies.

Molecular therapy : the journal of the American Society of Gene Therapy
2025

Mitochondrial Reactive Oxygen Species Production in Vascular Dementia Following Experimental Diabetes.

Cells
2025

Celastrol protected the MPTP-injected mice Parkinson's disease model via redox regulation of CDC37.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2025

The role of pyruvate metabolism in cardiovascular diseases.

The Journal of pharmacology and experimental therapeutics
2025

[Effect and mechanism of DDX21 on improving myocardial ischemia-reperfusion injury by regulating ATP5J alternative splicing].

Zhonghua xin xue guan bing za zhi
2025

Tissue-Specific Regulation of Fatty Acid Metabolism in a Mouse Model of Isolated Complex I Deficiency.

Proteomics
2025

Assessment of the respiratory chain enzyme activity in peripheral blood monocytes for the noninvasive diagnostics of mitochondrial disease.

World journal of pediatrics : WJP
2025

Mitochondrial Oxidative Phosphorylation System Dysfunction in Schizophrenia.

International journal of molecular sciences
2025

Evidence of Hyperacetylation of Mitochondrial Regulatory Proteins in Left Ventricular Myocardium of Dogs with Chronic Heart Failure.

International journal of molecular sciences
2025

Extracellular vesicles from hiPSC-derived NSCs protect human neurons against Aβ-42 oligomers induced neurodegeneration, mitochondrial dysfunction and tau phosphorylation.

Stem cell research &amp; therapy
2025

MitoSNO inhibits mitochondrial hydrogen peroxide generation by α-ketoglutarate dehydrogenase.

The Journal of biological chemistry
2025

Exploring Human Brain Metabolism via Genome-Scale Metabolic Modeling with Highlights on Multiple Sclerosis.

ACS chemical neuroscience
2025

Folium Hibisci Mutabilis extract suppresses M1 macrophage polarization through mitochondrial function enhancement in murine acute gouty arthritis.

Chinese medicine
2025

Proteomics and phosphoproteomics analysis of acute pancreatitis alleviated by forsythoside B.

Journal of proteomics
2024

Characterization of an in vitro model to study CD4+ T cell metabolism in dairy cows.

JDS communications
2025

Ndufs4 knockout mice with isolated complex I deficiency engage a futile adaptive brain response.

Biochimica et biophysica acta. Proteins and proteomics
2024

Unveiling the glycolysis in sepsis: Integrated bioinformatics and machine learning analysis identifies crucial roles for IER3, DSC2, and PPARG in disease pathogenesis.

Medicine
2024

Vgll2 as an integrative regulator of mitochondrial function and contractility specific to skeletal muscle.

Journal of cellular physiology
2024

IARS2 mutations lead to Leigh syndrome with a combined oxidative phosphorylation deficiency.

Orphanet journal of rare diseases
2024

A common variant in the iron regulatory gene (Hfe) alters the metabolic and transcriptional landscape in brain regions vulnerable to neurodegeneration.

Journal of neurochemistry
2024

An efficient and high-throughput method for the evaluation of mitochondrial dysfunction in frozen brain samples after traumatic brain injury.

Frontiers in molecular biosciences
2024

Decreasing Intracellular Entropy by Increasing Mitochondrial Efficiency and Reducing ROS Formation-The Effect on the Ageing Process and Age-Related Damage.

International journal of molecular sciences
2024

Mitochondria Transplantation: Rescuing Innate Muscle Bioenergetic Impairment in a Model of Aging and Exercise Intolerance.

Journal of strength and conditioning research
2024

Aberrant PGC-1α signaling in a lamb model of persistent pulmonary hypertension of the newborn.

Pediatric research
2024

Blood RNA-sequencing across the continuum of ANA-positive autoimmunity reveals insights into initiating immunopathology.

Annals of the rheumatic diseases
2024

Lack of mitochondrial complex I assembly factor NDUFAF2 results in a distinctive infantile-onset brainstem neurodegenerative disease with early lethality.

Orphanet journal of rare diseases
2024

A Potential "Anti-Warburg Effect" in Circulating Tumor Cell-mediated Metastatic Progression?

Aging and disease
2024

The striking differences in the bioenergetics of brain and liver mitochondria are enhanced in mitochondrial disease.

Biochimica et biophysica acta. Molecular basis of disease
2024

Postnatal growth restriction alters myocardial mitochondrial energetics in mice.

Experimental physiology
2024

Free radical scavenging polyphenols isolated from Phyllanthus niruri L. ameliorates hyperglycemia via SIRT1 induction and GLUT4 translocation in in vitro and in vivo models.

Fitoterapia
2023

Western diet-induced obesity results in brain mitochondrial dysfunction in female Ossabaw swine.

Frontiers in molecular neuroscience
2023

Modulation of mitochondrial function with near-infrared light reduces brain injury in a translational model of cardiac arrest.

Critical care (London, England)
2023

Protection against Aβ-induced neuronal damage by KU-32: PDHK1 inhibition as important target.

Frontiers in aging neuroscience
2023

Mitochondrial hypermetabolism precedes impaired autophagy and synaptic disorganization in App knock-in Alzheimer mouse models.

Molecular psychiatry
2023

The AMPK activator metformin improves recovery from demyelination by shifting oligodendrocyte bioenergetics and accelerating OPC differentiation.

Frontiers in cellular neuroscience
2023

Astrocytes of the optic nerve exhibit a region-specific and temporally distinct response to elevated intraocular pressure.

Molecular neurodegeneration
2023

Resistance Exercise Training Rescues Mitochondrial Dysfunction in Skeletal Muscle of Patients with Myotonic Dystrophy Type 1.

Journal of neuromuscular diseases
2023

Identification of potential functional peptides involved in demyelinating injury in the central nervous system.

PeerJ
2023

Intranasal insulin treatment partially corrects the altered gene expression profile in the hippocampus of developing rats with perinatal iron deficiency.

American journal of physiology. Regulatory, integrative and comparative physiology
2023

Elevated CHCHD4 orchestrates mitochondrial oxidative phosphorylation to disturb hypoxic pulmonary hypertension.

Journal of translational medicine
2023

Different Effects of SSRIs, Bupropion, and Trazodone on Mitochondrial Functions and Monoamine Oxidase Isoform Activity.

Antioxidants (Basel, Switzerland)
2023

Loss of cholinergic receptor muscarinic 1 impairs cortical mitochondrial structure and function: implications in Alzheimer's disease.

Frontiers in cell and developmental biology
2023

The harmful acute effects of clomipramine in the rat liver: Impairments in mitochondrial bioenergetics.

Toxicology letters
2023

Severe neonatal onset neuroregression with paroxysmal dystonia and apnoea: Expanding the phenotypic and genotypic spectrum of CARS2-related mitochondrial disease.

JIMD reports
2023

Mitochondrial complex III deficiency drives c-MYC overexpression and illicit cell cycle entry leading to senescence and segmental progeria.

Nature communications
2023

Modeling of clinical phenotypes in systemic lupus erythematosus based on the platelet transcriptome and FCGR2a genotype.

Journal of translational medicine
2023

In Vivo and In Vitro Expression of iC1, a Methylation-Controlled J Protein (MCJ) in Bovine Liver, and Response to In Vitro Bovine Fatty Liver Disease Model.

Animals : an open access journal from MDPI
2023

Impact of the m.13513G>A Variant on the Functions of the OXPHOS System and Cell Retrograde Signaling.

Current issues in molecular biology
2023

Killing Two Birds with One Stone: Discovery of Dual Inhibitors of Oxygen and Fumarate Respiration in Zoonotic Parasite, Echinococcus multilocularis.

Antimicrobial agents and chemotherapy
2023

The Intracellular Amastigote of Trypanosoma cruzi Maintains an Actively Beating Flagellum.

mBio
2023

Monitoring mitochondrial translation by pulse SILAC.

The Journal of biological chemistry
2022

Grim-19 plays a key role in mitochondrial steroidogenic acute regulatory protein stability and ligand-binding properties in Leydig cells.

The Journal of biological chemistry
2022

Rat Group IIA Secreted Phospholipase A2 Binds to Cytochrome c Oxidase and Inhibits Its Activity: A Possible Episode in the Development of Alzheimer's Disease.

International journal of molecular sciences
2022

A-Kinase Anchor Protein 1 deficiency causes mitochondrial dysfunction in mouse model of hyperoxia induced acute lung injury.

Frontiers in pharmacology
2022

Extreme intraspecific divergence in mitochondrial haplotypes makes the threespine stickleback fish an emerging evolutionary mutant model for mito-nuclear interactions.

Frontiers in genetics
2022

Mitochondrial Genome Variants as a Cause of Mitochondrial Cardiomyopathy.

Cells
2022

Tafazzin deficiency attenuates anti-cluster of differentiation 40 and interleukin-4 activation of mouse B lymphocytes.

Cell and tissue research
2022

Structural modification of octadecanoic acid-3,4-tetrahydrofuran diester and the acaricidal activity and mechanism of its derivatives against Sarcoptes scabiei var. Cuniculi.

Frontiers in pharmacology
2022

A transcriptomic analysis of cerebral microvessels reveals the involvement of Notch1 signaling in endothelial mitochondrial-dysfunction-dependent BBB disruption.

Fluids and barriers of the CNS
2022

Chronic Fluoxetine Treatment of Socially Isolated Rats Modulates Prefrontal Cortex Proteome.

Neuroscience
2022

Analysis of Organization and Activity of Mitochondrial Respiratory Chain Complexes in Primary Fibroblasts Using Blue Native PAGE.

Methods in molecular biology (Clifton, N.J.)
2022

Characterizing the Electron Transport Chain: Structural Approach.

Methods in molecular biology (Clifton, N.J.)
2022

Adaptation of Oxidative Phosphorylation Machinery Compensates for Hepatic Lipotoxicity in Early Stages of MAFLD.

International journal of molecular sciences
2022

Mesenchymal stem cells improve redox homeostasis and mitochondrial respiration in fibroblast cell lines with pathogenic MT-ND3 and MT-ND6 variants.

Stem cell research &amp; therapy
2022

Acute stress deteriorates breast meat quality of Ross 308 broiler chickens by inducing redox imbalance and mitochondrial dysfunction.

Journal of animal science
2022

ß-Hydroxybutyrate Improves Mitochondrial Function After Transient Ischemia in the Mouse.

Neurochemical research
2022

Hydnocarpin D attenuates lipopolysaccharide-induced acute lung injury via MAPK/NF-κB and Keap1/Nrf2/HO-1 pathway.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2022

Estrogen-Related Receptor γ Maintains Pancreatic Acinar Cell Function and Identity by Regulating Cellular Metabolism.

Gastroenterology
2022

Measurement of Protein Import Capacity of Skeletal Muscle Mitochondria.

Journal of visualized experiments : JoVE
2021

Mitochondrial Retinopathies.

International journal of molecular sciences
2021

Comparative Proteomic Profiling Identifies Reciprocal Expression of Mitochondrial Proteins Between White and Gray Matter Lesions From Multiple Sclerosis Brains.

Frontiers in neurology
2022

Calpain-mediated protein targets in cardiac mitochondria following ischemia-reperfusion.

Scientific reports
2021

Effects of Magnesium Orotate, Benfotiamine and a Combination of Vitamins on Mitochondrial and Cholinergic Function in the TgF344-AD Rat Model of Alzheimer's Disease.

Pharmaceuticals (Basel, Switzerland)
2022

Ndufs4 knockout mouse models of Leigh syndrome: pathophysiology and intervention.

Brain : a journal of neurology
2021

The Effect of Tuberculosis Antimicrobials on the Immunometabolic Profiles of Primary Human Macrophages Stimulated with Mycobacterium tuberculosis.

International journal of molecular sciences
2021

Comparative Study of Functional Changes in Heart Mitochondria in Two Modes of Epinephrine Exposure Modeling Myocardial Injury in Rats.

Bulletin of experimental biology and medicine
2021

Exercise prevents fatty liver by modifying the compensatory response of mitochondrial metabolism to excess substrate availability.

Molecular metabolism
2021

Loss of major nutrient sensing and signaling pathways suppresses starvation lethality in electron transport chain mutants.

Molecular biology of the cell
2021

The Energy Status of Astrocytes Is the Achilles' Heel of eIF2B-Leukodystrophy.

Cells
2021

oxLDL-Induced Trained Immunity Is Dependent on Mitochondrial Metabolic Reprogramming.

Immunometabolism
2021

Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer's Disease.

Molecular neurobiology
2021

Targeting JAK-STAT Signalling Alters PsA Synovial Fibroblast Pro-Inflammatory and Metabolic Function.

Frontiers in immunology
2021

Prostate cancer cells survive anti-androgen and mitochondrial metabolic inhibitors by modulating glycolysis and mitochondrial metabolic activities.

The Prostate
2021

Determination of Oxidative Phosphorylation Complexes Activities.

Methods in molecular biology (Clifton, N.J.)
2021

Molecular Epidemiology of Mitochondrial Cardiomyopathy: A Search Among Mitochondrial and Nuclear Genes.

International journal of molecular sciences
2021

Optic atrophy-associated TMEM126A is an assembly factor for the ND4-module of mitochondrial complex I.

Proceedings of the National Academy of Sciences of the United States of America
2021

Improvement of Platelet Respiration by Cell-Permeable Succinate in Diabetic Patients Treated with Statins.

Life (Basel, Switzerland)
2021

Metabolic Changes in Peripheral Blood Mononuclear Cells Isolated From Patients With End Stage Renal Disease.

Frontiers in endocrinology
2021

Naked mole-rat skeletal muscle mitochondria exhibit minimal functional plasticity in acute or chronic hypoxia.

Comparative biochemistry and physiology. Part B, Biochemistry &amp; molecular biology
2021

Direct Cardiac Actions of the Sodium Glucose Co-Transporter 2 Inhibitor Empagliflozin Improve Myocardial Oxidative Phosphorylation and Attenuate Pressure-Overload Heart Failure.

Journal of the American Heart Association
2021

Structural basis for a complex I mutation that blocks pathological ROS production.

Nature communications
2021

Severe congenital lactic acidosis and hypertrophic cardiomyopathy caused by an intronic variant in NDUFB7.

Human mutation
2021

Dysregulation of Metabolic Pathways in Circulating Natural Killer Cells Isolated from Inflammatory Bowel Disease Patients.

Journal of Crohn's &amp; colitis
2021

Autism spectrum disorder (ASD)-associated mitochondrial deficits are revealed in children's platelets but unimproved by hyperbaric oxygen therapy.

Free radical research
2021

Cell-Permeable Succinate Rescues Mitochondrial Respiration in Cellular Models of Statin Toxicity.

International journal of molecular sciences
2020

Dysfunctional Mitochondrial Dynamic and Oxidative Phosphorylation Precedes Cardiac Dysfunction in R120G-αB-Crystallin-Induced Desmin-Related Cardiomyopathy.

Journal of the American Heart Association
2020

The genetic basis of isolated mitochondrial complex II deficiency.

Molecular genetics and metabolism
2020

Biallelic mutations in NDUFA8 cause complex I deficiency in two siblings with favorable clinical evolution.

Molecular genetics and metabolism
2020

Chemical Pathology of Homocysteine VIII. Effects of Tocotrienol, Geranylgeraniol, and Squalene on Thioretinaco Ozonide, Mitochondrial Permeability, and Oxidative Phosphorylation in Arteriosclerosis, Cancer, Neurodegeneration and Aging.

Annals of clinical and laboratory science
2020

A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.

Journal of translational medicine
2020

Chinese liquor extract attenuates oxidative damage in HepG2 cells and extends lifespan of Caenorhabditis elegans.

Food science &amp; nutrition
2020

Novel NDUFA13 Mutations Associated with OXPHOS Deficiency and Leigh Syndrome: A Second Family Report.

Genes
2020

Mechanisms and roles of mitochondrial localisation and dynamics in neuronal function.

Neuronal signaling
2020

Opa1 Overexpression Protects from Early-Onset Mpv17-/--Related Mouse Kidney Disease.

Molecular therapy : the journal of the American Society of Gene Therapy
2021

Loss of SIRT1 in diabetes accelerates DNA damage-induced vascular calcification.

Cardiovascular research
2020

Mitochondrial oxidative phosphorylation in peripheral blood mononuclear cells is decreased in chronic HIV and correlates with immune dysregulation.

PloS one
2020

Enhanced liver but not muscle OXPHOS in diabetes and reduced glucose output by complex I inhibition.

Journal of cellular and molecular medicine
2020

TAT-dextran-mediated mitochondrial transfer enhances recovery from models of reperfusion injury in cultured cardiomyocytes.

Journal of cellular and molecular medicine
2020

A neuroglobin-based high-affinity ligand trap reverses carbon monoxide-induced mitochondrial poisoning.

The Journal of biological chemistry
2020

Chlamydomonas reinhardtii as a plant model system to study mitochondrial complex I dysfunction.

Plant direct
2020

Mutations in FASTKD2 are associated with mitochondrial disease with multi-OXPHOS deficiency.

Human mutation
2020

In vitro effects of antidepressants and mood-stabilizing drugs on cell energy metabolism.

Naunyn-Schmiedeberg's archives of pharmacology
2020

Energization by multiple substrates and calcium challenge reveal dysfunctions in brain mitochondria in a model related to acute psychosis.

Journal of bioenergetics and biomembranes
2019

Multi-Omics Integration Reveals Short and Long-Term Effects of Gestational Hypoxia on the Heart Development.

Cells
2019

A novel variant m.8561C>T in the overlapping region of MT-ATP6 and MT-ATP8 in a child with early-onset severe neurological signs.

Molecular genetics and metabolism reports
2019

ASCs-Exosomes Recover Coupling Efficiency and Mitochondrial Membrane Potential in an in vitro Model of ALS.

Frontiers in neuroscience
2019

Glial mitochondrial function and dysfunction in health and neurodegeneration.

Molecular and cellular neurosciences
2019

A Shifty Target: Tumor-Initiating Cells and Their Metabolism.

International journal of molecular sciences
2019

4'-Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN.

EMBO molecular medicine
2019

Oxygraphy Versus Enzymology for the Biochemical Diagnosis of Primary Mitochondrial Disease.

Metabolites
2019

Cardioprotective effects of idebenone do not involve ROS scavenging: Evidence for mitochondrial complex I bypass in ischemia/reperfusion injury.

Journal of molecular and cellular cardiology
2019

Alterations in platelet bioenergetics in Group 2 PH-HFpEF patients.

PloS one
2019

First-line Screening of OXPHOS Deficiencies Using Microscale Oxygraphy in Human Skin Fibroblasts: A Preliminary Study.

International journal of medical sciences
2019

Uremic metabolites impair skeletal muscle mitochondrial energetics through disruption of the electron transport system and matrix dehydrogenase activity.

American journal of physiology. Cell physiology
2019

Mitochondrial Oxidative Phosphorylation defect in the Heart of Subjects with Coronary Artery Disease.

Scientific reports
2019

Pioglitazone Improves the Function of Human Mesenchymal Stem Cells in Chronic Kidney Disease Patients.

International journal of molecular sciences
2019

An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals.

PloS one
2019

Transient Introduction of miR-294 in the Heart Promotes Cardiomyocyte Cell Cycle Reentry After Injury.

Circulation research
2019

Cardiac Specific Knockout of p53 Decreases ER Stress-Induced Mitochondrial Damage.

Frontiers in cardiovascular medicine
2019

Mutations in the MRPS28 gene encoding the small mitoribosomal subunit protein bS1m in a patient with intrauterine growth retardation, craniofacial dysmorphism and multisystemic involvement.

Human molecular genetics
2018

Baicalein protects human vitiligo melanocytes from oxidative stress through activation of NF-E2-related factor2 (Nrf2) signaling pathway.

Free radical biology &amp; medicine
2018

Is PNPT1-related hearing loss ever non-syndromic? Whole exome sequencing of adult siblings expands the natural history of PNPT1-related disorders.

American journal of medical genetics. Part A
2019

Isolation of mitochondrial subpopulations from skeletal muscle: Optimizing recovery and preserving integrity.

Acta physiologica (Oxford, England)
2018

Transcriptomic analysis reveals oxidative phosphorylation activation in an adolescent social isolation rat model.

Brain research bulletin
2018

[Influence of the dense extract from herb of Primula veris L. On the oxidative stress development and the functional state of the cardiomyocytes mitochondria of rats with experimental chronic heart failure].

Biomeditsinskaia khimiia
2018

Adaptations of hepatic lipid metabolism and mitochondria in dairy cows with mild fatty liver.

Journal of dairy science
2018

Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis.

Journal of hepatology
2018

Cancer Stem Cell Metabolism and Potential Therapeutic Targets.

Frontiers in oncology
2018

Evaluation of Respiration with Clark-Type Electrode in Isolated Mitochondria and Permeabilized Animal Cells.

Methods in molecular biology (Clifton, N.J.)
2018

Use the Protonmotive Force: Mitochondrial Uncoupling and Reactive Oxygen Species.

Journal of molecular biology
2018

Analyzing mitochondrial function in human peripheral blood mononuclear cells.

Analytical biochemistry
2018

Ectopic expression of S28A-mutated Histone H3 modulates longevity, stress resistance and cardiac function in Drosophila.

Scientific reports
2018

NDUFB8 Mutations Cause Mitochondrial Complex I Deficiency in Individuals with Leigh-like Encephalomyopathy.

American journal of human genetics
2018

Reactive oxygen species induced Ca2+ influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension.

American journal of physiology. Lung cellular and molecular physiology
2017

Mitochondrial proteomic profile of complex IV deficiency fibroblasts: rearrangement of oxidative phosphorylation complex/supercomplex and other metabolic pathways.

Boletin medico del Hospital Infantil de Mexico
2017

Using a quantitative quadruple immunofluorescent assay to diagnose isolated mitochondrial Complex I deficiency.

Scientific reports
2017

Photo-affinity labelling and biochemical analyses identify the target of trypanocidal simplified natural product analogues.

PLoS neglected tropical diseases
2017

Honokiol induces superoxide production by targeting mitochondrial respiratory chain complex I in Candida albicans.

PloS one
2017

Mitochondrial estrogen receptors as a vulnerability factor of chronic stress and mediator of fluoxetine treatment in female and male rat hippocampus.

Brain research
2017

Grape seed procyanidin B2 ameliorates hepatic lipid metabolism disorders in db/db mice.

Molecular medicine reports
2017

Modulation of oxidative phosphorylation and redox homeostasis in mitochondrial NDUFS4 deficiency via mesenchymal stem cells.

Stem cell research &amp; therapy
2017

Cytochrome c Oxidase Activity Is a Metabolic Checkpoint that Regulates Cell Fate Decisions During T Cell Activation and Differentiation.

Cell metabolism
2017

Diabetes-induced abnormalities of mitochondrial function in rat brain cortex: the effect of n-3 fatty acid diet.

Molecular and cellular biochemistry
2017

Methylene blue stimulates substrate-level phosphorylation catalysed by succinyl-CoA ligase in the citric acid cycle.

Neuropharmacology
2017

Mutated PET117 causes complex IV deficiency and is associated with neurodevelopmental regression and medulla oblongata lesions.

Human genetics
2017

Gene-centric analysis implicates nuclear encoded mitochondrial protein gene variants in migraine susceptibility.

Molecular genetics &amp; genomic medicine
2017

Time courses of post-injury mitochondrial oxidative damage and respiratory dysfunction and neuronal cytoskeletal degradation in a rat model of focal traumatic brain injury.

Neurochemistry international
2017

Platelets from pulmonary hypertension patients show increased mitochondrial reserve capacity.

JCI insight
2016

Neuromuscular Manifestations in Mitochondrial Diseases in Children.

Seminars in pediatric neurology
2016

Knockout of Tmem70 alters biogenesis of ATP synthase and leads to embryonal lethality in mice.

Human molecular genetics
2017

Mitochondrial oxidative phosphorylation disorders in children: Phenotypic, genotypic and biochemical correlations in 85 patients from South India.

Mitochondrion
2016

Coriandrum sativum Suppresses Aβ42-Induced ROS Increases, Glial Cell Proliferation, and ERK Activation.

The American journal of Chinese medicine
2017

Curcumin prevents mitochondrial dynamics disturbances in early 5/6 nephrectomy: Relation to oxidative stress and mitochondrial bioenergetics.

BioFactors (Oxford, England)
2016

Triglyceride depletion of brown adipose tissue enables analysis of mitochondrial respiratory function in permeabilized biopsies.

Analytical biochemistry
2017

Resolution of mitochondrial oxidant stress improves aged-cardiovascular performance.

Coronary artery disease
2016

Immortalized Parkinson's disease lymphocytes have enhanced mitochondrial respiratory activity.

Disease models &amp; mechanisms
2016

Natural Product Screening Reveals Naphthoquinone Complex I Bypass Factors.

PloS one
2016

Aldehyde dehydrogenase 1a3 defines a subset of failing pancreatic β cells in diabetic mice.

Nature communications
2016

Evidence of a wide spectrum of cardiac involvement due to ACAD9 mutations: Report on nine patients.

Molecular genetics and metabolism
2016

Challenging the dogma of mitochondrial reactive oxygen species overproduction in diabetic kidney disease.

Kidney international
2016

Mitochondrial disorders in children: toward development of small-molecule treatment strategies.

EMBO molecular medicine
2016

NecroX-5 protects mitochondrial oxidative phosphorylation capacity and preserves PGC1α expression levels during hypoxia/reoxygenation injury.

The Korean journal of physiology &amp; pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
2016

Analysis of Mitochondrial Respiratory Chain Supercomplexes Using Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE).

Current protocols in mouse biology
2016

Mitochondrial dysfunction in inherited renal disease and acute kidney injury.

Nature reviews. Nephrology
2017

Effects of Aluminium on Rat Brain Mitochondria Bioenergetics: an In vitro and In vivo Study.

Molecular neurobiology
2014

Noninvasive diagnostics of mitochondrial disorders in isolated lymphocytes with high resolution respirometry.

BBA clinical
2016

Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.

International journal of urology : official journal of the Japanese Urological Association
2015

LRPPRC mutations cause early-onset multisystem mitochondrial disease outside of the French-Canadian population.

Brain : a journal of neurology
2015

Impaired mitochondrial energy supply coupled to increased H2O2 emission under energy/redox stress leads to myocardial dysfunction during Type I diabetes.

Clinical science (London, England : 1979)
2015

Glucose intolerance and pancreatic β-cell dysfunction in the anorectic anx/anx mouse.

American journal of physiology. Endocrinology and metabolism
2015

Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency.

Neurobiology of disease
2015

Mitochondrial bioenergetic alterations after focal traumatic brain injury in the immature brain.

Experimental neurology
2015

A recessive homozygous p.Asp92Gly SDHD mutation causes prenatal cardiomyopathy and a severe mitochondrial complex II deficiency.

Human genetics
2015

Myocardial mitochondrial dysfunction in mice lacking adiponectin receptor 1.

Basic research in cardiology
2015

Quantitative analysis of proteins of metabolism by reverse phase protein microarrays identifies potential biomarkers of rare neuromuscular diseases.

Journal of translational medicine
2015

Comprehensive Analysis of Transcriptome Sequencing Data in the Lung Tissues of COPD Subjects.

International journal of genomics
2015

Mitochondrial physiology in the major arbovirus vector Aedes aegypti: substrate preferences and sexual differences define respiratory capacity and superoxide production.

PloS one
2015

Impaired cardiac mitochondrial oxidative phosphorylation and enhanced mitochondrial oxidative stress in feline hypertrophic cardiomyopathy.

American journal of physiology. Heart and circulatory physiology

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença isolada do complexo da fosforilação oxidativa.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Doença isolada do complexo da fosforilação oxidativa

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Screening strategy using a filamentous fungus model to repurpose drugs for mitochondrial complex I deficiencies.
    Life sciences· 2026· PMID 41644045mais citado
  2. Structural basis for late maturation steps of mitochondrial respiratory chain complex IV within the human respirasome.
    Nature communications· 2026· PMID 41519940mais citado
  3. Elamipretide Improves Mitochondrial Function in Mitochondrial Trifunctional Protein-Deficient Mice and Human Fibroblasts.
    Journal of inherited metabolic disease· 2026· PMID 41500837mais citado
  4. Immune Cell Mitochondrial Phenotypes Are Largely Preserved in Mitochondrial Diseases and Do Not Reflect Disease Severity.
    Neurology. Genetics· 2026· PMID 41488384mais citado
  5. Bmal1 regulates thermogenic function by modulation of lipolytic and OXPHOS gene expression in male mice brown adipocytes.
    Endocrinology· 2026· PMID 41749434mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:254846(Orphanet)
  2. MONDO:0000066(MONDO)
  3. Variantes catalogadas(ClinVar)
  4. Q55786477(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Doença isolada do complexo da fosforilação oxidativa
Compêndio · Raras BR

Doença isolada do complexo da fosforilação oxidativa

ORPHA:254846 · MONDO:0000066
MedGen
UMLS
C5679632
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades